GVR Report cover Pharmaceutical Analytical Testing Outsourcing Market Size, Share & Trends Report

Pharmaceutical Analytical Testing Outsourcing Market Size, Share & Trends Analysis Report By Service (Bioanalytical Testing, Method Development and Validation, Stability Testing), By End Use, By Region, And Segment Forecasts, 2024 - 2030

  • Report ID: GVR-1-68038-365-2
  • Number of Report Pages: 187
  • Format: PDF, Horizon Databook
  • Historical Range: 2018 - 2021
  • Forecast Period: 2023 - 2030 
  • Industry: Healthcare

Market Size & Trends

The global pharmaceutical analytical testing outsourcing market size was valued at USD 8.3 billion in 2023 and is projected to grow at a CAGR of 8.4% from 2024 to 2030. Growth in the market can be attributed due to increasing focus toward safety, & quality; regulation, pricing benefits of outsourcing, and rising number of end use. Besides, increasing R&D investment is one of the critical sustainability strategies adopted by market players. As, not all companies have an infrastructure for analytical testing. Therefore, outsourcing these operations is a suitable option, which helps to save time and cost.

U.S. Pharmaceutical Analytical Testing Outsourcing market size and growth rate, 2023 - 2030

Other factors, such as the changing regulations for in vivo and in vitro tests, are also expected to propel the growth of the market for pharmaceutical analytical testing outsourcing. Besides, high demand for quality generic drugs, analytical testing methods, improved the quality and transparency of the review & approval process, and encourage new drug R&D in line with global development is anticipated to fuel the market growth.

In addition, innovation or new product development is directly proportional to the demand for testing services due to pricing concerns, competitive pressures, and lead-time to market, companies are opting for outsourcing of testing services. Moreover, focus on customized care and technological advancements, which has resulted in rapid development of new products. Likewise, development of biosimilar, combination products, and other innovative medicines has fueled the demand for pharmaceutical analytical testing services.  

Market Concentration & Characteristics

The market growth stage is stable, and market growth is expected to accelerate over the estimated time period. The pharmaceutical analytical testing outsourcing market is characterized by testing regulations, evolving technologies, and globalization & outsourcing of services.

Pharmaceutical Analytical Testing Outsourcing Market Concentration & Characteristics

The pharmaceutical analytical testing outsourcing market is anticipated to witness lucrative growth due to theincreasing R&D investments, pharmaceutical testing methods, pharmaceutical outsourcing companies to reduce costs, improve efficiency, and focus on core competencies. Besides, increasing awareness about product quality, and safety among consumers is driving companies to outsource tests as a means to ensure that the product complies with aforementioned aspects, thereby building a brand image and protecting & enhancing its reputation.

In addition, the market is highly competitive, characterized by numerous established and emerging players offering a wide array of services. Besides, the performance of market players in pharmaceutical analytical testing domain is highly influenced by the level of demand from the end-use side. In addition, due to intense market efforts, and pharma outsourcing trends are shaping the pharmaceutical sector’s landscape, such as regional expansion, shifting of facilities to low-cost regions, and increasing collaborations, are likely to meet the future demand.

Degree of Innovation: Ongoing additional quality testing parameters in formulation create opportunities for contract manufacturers to differentiate themselves by offering innovative drug forms production with quality and quantity. Besides, pharmaceutical companies are outsourcing the business activities to increase cost efficiency, productivity, and higher focus on innovation.

Impact of Regulations:  New regulations, strong technical expertise in pharmaceutical formulation & regulatory compliance allows companies to offer high-quality testing enabling better deals with suppliers, invest in advanced technologies, and offer competitive pricing. This enhances their market competitiveness and profitability.

Level of M&A Activities: Various market players, such asLabcorp, SGS S.A., Eurofins Scientific, Intertek Group Plc, Pace Analytical Services, Inc., and WuXi AppTec are involved in merger and acquisition activities. Through M&A activity, these entities can expand their geographic reach and strengthen their market position.

Market Fragmentation: A continuation of expansion of manufacturing capacity by CMOS & CDMOS and increase in the number of local players and established market players manufacturing innovator drugs is expected to improve the demand for pharmaceutical analytical testing services. Therefore, the pharmaceutical industry is expected to witness abundant outsourcing activities.

Regional Expansion: The expansion of the market in the region can be attributed to the presence of technologically advanced contract manufacturing organizations (CMOs) & Contract Development and Manufacturing Organizations (CDMOs) and increasing focus on customized care. Furthermore, rapid development of new products, increase in demand for specific types of tests, the presence of pharmaceutical companies, and a surge in the increase operational efficiency, therapeutic expertise in the region is propelling the market growth.

Services Insights

On the basis of services segment, the market is classified into bioanalytical testing, method development & validation, stability testing, and others. Bioanalytical testing includes clinical and non-clinical. Similarly, method development & validation is segregated into extractable & leachable, technical consulting, impurity method, and others. Likewise, stability testing includes drug substance, stability indicating method validation, photostability testing, accelerated stability testing, and others. Other service segments held the largest share of over 40.0% in 2023. The segment includes environmental monitoring, raw material testing, batch release, microbial testing, and physical characterization of the materials. Changing regulations for in vivo and in vitro tests and innovative approaches to reduce the complexity of the tests are contributing to the segment’s growth.

The bioanalytical testing services segment is expected to witness the fastest growth over the forecast period. The entry of new participants into the market and an increasing number of clinical trial registrations have contributed to the segment’s growth. A lot of small-scale industries are not equipped with top-end analytical tools and opt for outsourcing these studies to industry experts having years of experience in performing, documenting, and adapting to the challenges presented during analysis. This is also anticipated to drive segment growth.

End Use Insights

On the basis of end use segment, the market is segregated into pharmaceutical companies, biopharmaceutical companies, contract research organizations. The pharmaceutical companies segment dominated the global pharmaceutical analytical testing outsourcing market and accounted for a revenue share of over 47.2% in 2023. There are a significant number of small-sized pharmaceutical companies globally that lack in-house analytical testing capabilities. This has encouraged small-sized pharmaceutical companies to collaborate with CROs to assist them with analytical testing services. Outsourcing analytical testing services also saves time for the pharmaceutical company, thus helping them focus on their core competence. This further supports the growth of the segment market.

The biopharmaceutical companies’ segment is estimated to show growth at a lucrative rate in the market over the forecast period. Growth in the segment can be attributed to demand for testing in biopharmaceutical companies to improve productivity, characterize biologics and biosimilars, and provide real-time product quality control. Biopharmaceutical analytical testing requires specialized staff to run the assays and prepare regulatory filings. This reason has significantly contributed to the demand for outsourcing biopharmaceutical analytical services to an expert team and thus is expected to have a positive impact on the segment market.

Regional Insights

North America dominated the global pharmaceutical analytical testing outsourcing market in 2023, holding a revenue share of 53.17%. This growth can be attributed to various factors such as highly reliable, high-end, and complex pharmaceuticals. Moreover, original equipment manufacturers are increasingly shifting toward electronics manufacturing service providers to efficiently manage the high volume of electronic components in current pharmaceuticals. In addition, increasing number of pharmaceutical industries within U.S. & Canada, and presence of number of major market players this region is expected to contribute significantly to the market growth.

Global pharmaceutical analytical testing outsourcing market share and size, 2022

Asia Pacific is expected to show growth at a lucrative rate in the market over the forecast period owing to growing investments and market players expanding its presence in the Asia Pacific region. Such expansions across Asia Pacific regional countries are likely to have a positive impact on the Asia Pacific market. For instance, pharma outsourcing trends in India is attributed to low costs, availability of industry experts, and presence of WHO-cGMP compliant facilities.

Key Pharmaceutical Analytical Testing Outsourcing Company Insights

The pharmaceutical analytical testing outsourcing market is fragmented with the presence of emerging and established market players. In addition, growing number of pharmaceutical companies, and increasing manufacturing capabilities is creating competitiveness of the market. Therefore, prominent strategies adopted by companies are acquisitions, collaborations, expansion, services launch, partnerships and others to increase market presence & revenue and gain a competitive edge. Players in the market undertake this strategy to strengthen their product portfolios and offer diverse services to customers.

Key Pharmaceutical Analytical Testing Outsourcing Companies:

The following are the leading companies in the pharmaceutical analytical testing outsourcing market. These companies collectively hold the largest market share and dictate industry trends. Financials, strategy maps & products of these pharmaceutical analytical testing outsourcing companies are analyzed to map the supply network.

  • SGS SA
  • Labcorp
  • Eurofins Scientific
  • Pace Analytical Services LLC
  • Intertek Group plc
  • PPD Inc (Thermo fisher Scietific, Inc.)
  • Wuxi AppTec
  • Boston Analytical
  • Charles River Laboratories
  • West Pharmaceutical Services, Inc

Recent Developments

  • In December 2023, Agno Pharma acquired Lubrizol Particle Sciences Inc. The acquisition encompasses the drug product formulation technology integral to Particle Sciences Inc. including the PA, Bethlehem development & manufacturing site.

  • In November 2023,Eurofins acquired Quasfar supporting the pharmaceutical industry in Latin America, enhancing its capabilities in R&D, providing support in the early stages of pharmaceutical product development.

Pharmaceutical Analytical Testing Outsourcing Market Report Scope

Report Attribute

Details

Market size value in 2024

 USD 9.0 billion

Revenue forecast in 2030

USD 14.6 billion

Growth rate

CAGR of 8.4% from 2024 to 2030

Historical Year

2018 - 2023

Forecast period

2024 - 2030

Quantitative units

Revenue in USD Million and CAGR from 2024 to 2030

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

 Services, end use,region

Regional scope

North America, Europe, Asia Pacific, Latin America, MEA

Country scope

U.S., Canada, UK, Germany, France, Italy, Spain, Denmark, Sweden, Norway, China, India, Japan, Australia, South Korea, Thailand, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, UAE, Kuwait

Key companies profiled

SGS SA, Labcorp, Eurofins Scientific, Pace Analytical Services LLC, Intertek Group plc, PPD Inc (Thermo fisher Scietific, Inc.), Wuxi AppTec, Boston Analytical, Charles River Laboratories, Pharmaceutical Services, Inc

Customization scope

Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

 

Global Pharmaceutical Analytical Testing Outsourcing Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global pharmaceutical analytical testing outsourcing market report based on services, end use and region:

Global Pharmaceutical Analytical Testing Outsourcing Market Report Segmentation

  • Services Outlook (Revenue, USD Million, 2018 - 2030)

    • Bioanalytical Testing

      • Clinical

      • Non-clinical

    • Method Development & Validation

      • Extractable & Leachable

      • Impurity Method

      • Technical Consulting

      • Others

    • Stability Testing

      • Drug Substance

      • Stability Indicating Method Validation

      • Accelerated Stability Testing

      • Photostability Testing

      • Others

    • Others

  • End Use Outlook (Revenue, USD Million, 2018 - 2030)

    • Pharmaceutical Companies

    • Biopharmaceutical Companies

    • Contract Research Organizations

  • Regional Outlook (Revenue, USD Million, 2018 - 2030) 

    • North America

      • U.S.

      • Canada

    • Europe

      • UK

      • Germany

      • France

      • Italy

      • Spain

      • Denmark

      • Sweden

      • Norway

    • Asia Pacific

      • China

      • India

      • Japan

      • Australia

      • South Korea

      • Thailand

    • Latin America

      • Brazil

      • Mexico

      • Argentina

    • Middle East and Africa (MEA)

      • South Africa

      • Saudi Arabia

      • UAE

      • Kuwait

Frequently Asked Questions About This Report

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Segment Definitions
                        1.2.1. Services
                        1.2.2. End Use
                        1.2.3. Regional scope
                        1.2.4. Estimates and forecasts timeline
                    1.3. Research Methodology
                    1.4. Information Procurement
                        1.4.1. Purchased database
                        1.4.2. GVR’s internal database
                        1.4.3. Secondary sources
                        1.4.4. Primary research
                        1.4.5. Details of primary research
                            1.4.5.1. Data for primary interviews in North America
                            1.4.5.2. Data for primary interviews in Europe
                            1.4.5.3. Data for primary interviews in Asia Pacific
                            1.4.5.4. Data for primary interviews in Latin America
                            1.4.5.5. Data for Primary interviews in MEA
                    1.5. Information or Data Analysis
                        1.5.1. Data analysis models
                    1.6. Market Formulation & Validation
                    1.7. Model Details
                        1.7.1. Commodity flow analysis (Model 1)
                        1.7.2. Approach 1: Commodity flow approach
                        1.7.3. Volume price analysis (Model 2)
                        1.7.4. Approach 2: Volume price analysis
                    1.8. List of Secondary Sources
                    1.9. List of Primary Sources
                    1.10. Objectives
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                        2.2.1. Services outlook
                        2.2.2. End Use outlook
                        2.2.3. Regional outlook
                    2.3. Competitive Insights
Chapter 3. Pharmaceutical Analytical Testing Outsourcing Market Variables, Trends & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent market outlook
                        3.1.2. Related/ancillary market outlook
                    3.2. Market Dynamics
                        3.2.1. Market driver analysis
                            3.2.1.1. Increasing Innovation and product development
                            3.2.1.2. Growing demand for Regulation on safety and quality
                            3.2.1.3. Rising End-users volume
                            3.2.1.4. Pricing strategies
                        3.2.2. Market restraint analysis
                            3.2.2.1. Data insecurity
                            3.2.2.2. Third-party performance
                    3.3. Pharmaceutical Analytical Testing Outsourcing Market Analysis Tools
                        3.3.1. Industry Analysis - Porter’s
                            3.3.1.1. Supplier power
                            3.3.1.2. Buyer power
                            3.3.1.3. Substitution threat
                            3.3.1.4. Threat of new entrant
                            3.3.1.5. Competitive rivalry
                        3.3.2. PESTEL Analysis
Chapter 4. Pharmaceutical Analytical Testing Outsourcing Market: Services Estimates & Trend Analysis
                    4.1. Services Market Share, 2023 & 2030
                    4.2. Segment Dashboard
                    4.3. Global Pharmaceutical Analytical Testing Outsourcing Market by Services Outlook
                    4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                        4.4.1. Bioanalytical Testing
                            4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                            4.4.1.2. Clinical Market estimates and forecasts 2018 to 2030 (USD Million)
                            4.4.1.3. Non-Clinical Market estimates and forecasts 2018 to 2030 (USD Million)
                        4.4.2. Method Development & Validation
                            4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                            4.4.2.2. Extractable & Leachable Market estimates and forecasts 2018 to 2030 (USD Million)
                            4.4.2.3. Impurity Method Market estimates and forecasts 2018 to 2030 (USD Million)
                            4.4.2.4. Technical Consulting Market estimates and forecasts 2018 to 2030 (USD Million)
                            4.4.2.5. Others Market estimates and forecasts 2018 to 2030 (USD Million)
                        4.4.3. Stability Testing
                            4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                            4.4.3.2. Drug Substance Market estimates and forecasts 2018 to 2030 (USD Million)
                            4.4.3.3. Stability Indicating Method Validation Market estimates and forecasts 2018 to 2030 (USD Million)
                            4.4.3.4. Accelerated Stability Testing Market estimates and forecasts 2018 to 2030 (USD Million)
                            4.4.3.5. Photostability Testing Market estimates and forecasts 2018 to 2030 (USD Million)
                            4.4.3.6. Others Market estimates and forecasts 2018 to 2030 (USD Million)
                        4.4.4. Other
                            4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Pharmaceutical Analytical Testing Outsourcing Market: End Use Estimates & Trend Analysis
                    5.1. End Use Market Share, 2023 & 2030
                    5.2. Segment Dashboard
                    5.3. Global Pharmaceutical Analytical Testing Outsourcing Market by End Use Outlook
                    5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                        5.4.1. Pharmaceutical Companies
                            5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        5.4.2. Biopharmaceutical Companies
                            5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        5.4.3. Contract Research Organizations
                            5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Pharmaceutical Analytical Testing Outsourcing Market: Regional Estimates & Trend Analysis
                    6.1. Regional Market Share Analysis, 2023 & 2030
                    6.2. Regional Market Dashboard
                    6.3. Global Regional Market Snapshot
                    6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
                    6.5. North America
                        6.5.1. U.S.
                            6.5.1.1. Key country dynamics
                            6.5.1.2. Regulatory framework/ reimbursement structure
                            6.5.1.3. Competitive scenario
                            6.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
                        6.5.2. Canada
                            6.5.2.1. Key country dynamics
                            6.5.2.2. Regulatory framework/ reimbursement structure
                            6.5.2.3. Competitive scenario
                            6.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
                    6.6. Europe
                        6.6.1. UK
                            6.6.1.1. Key country dynamics
                            6.6.1.2. Regulatory framework/ reimbursement structure
                            6.6.1.3. Competitive scenario
                            6.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
                        6.6.2. Germany
                            6.6.2.1. Key country dynamics
                            6.6.2.2. Regulatory framework/ reimbursement structure
                            6.6.2.3. Competitive scenario
                            6.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
                        6.6.3. France
                            6.6.3.1. Key country dynamics
                            6.6.3.2. Regulatory framework/ reimbursement structure
                            6.6.3.3. Competitive scenario
                            6.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
                        6.6.4. Italy
                            6.6.4.1. Key country dynamics
                            6.6.4.2. Regulatory framework/ reimbursement structure
                            6.6.4.3. Competitive scenario
                            6.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
                        6.6.5. Spain
                            6.6.5.1. Key country dynamics
                            6.6.5.2. Regulatory framework/ reimbursement structure
                            6.6.5.3. Competitive scenario
                            6.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
                        6.6.6. Norway
                            6.6.6.1. Key country dynamics
                            6.6.6.2. Regulatory framework/ reimbursement structure
                            6.6.6.3. Competitive scenario
                            6.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
                        6.6.7. Sweden
                            6.6.7.1. Key country dynamics
                            6.6.7.2. Regulatory framework/ reimbursement structure
                            6.6.7.3. Competitive scenario
                            6.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
                        6.6.8. Denmark
                            6.6.8.1. Key country dynamics
                            6.6.8.2. Regulatory framework/ reimbursement structure
                            6.6.8.3. Competitive scenario
                            6.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
                    6.7. Asia Pacific
                        6.7.1. Japan
                            6.7.1.1. Key country dynamics
                            6.7.1.2. Regulatory framework/ reimbursement structure
                            6.7.1.3. Competitive scenario
                            6.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
                        6.7.2. China
                            6.7.2.1. Key country dynamics
                            6.7.2.2. Regulatory framework/ reimbursement structure
                            6.7.2.3. Competitive scenario
                            6.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
                        6.7.3. India
                            6.7.3.1. Key country dynamics
                            6.7.3.2. Regulatory framework/ reimbursement structure
                            6.7.3.3. Competitive scenario
                            6.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
                        6.7.4. Australia
                            6.7.4.1. Key country dynamics
                            6.7.4.2. Regulatory framework/ reimbursement structure
                            6.7.4.3. Competitive scenario
                            6.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
                        6.7.5. South Korea
                            6.7.5.1. Key country dynamics
                            6.7.5.2. Regulatory framework/ reimbursement structure
                            6.7.5.3. Competitive scenario
                            6.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
                        6.7.6. Thailand
                            6.7.6.1. Key country dynamics
                            6.7.6.2. Regulatory framework/ reimbursement structure
                            6.7.6.3. Competitive scenario
                            6.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
                    6.8. Latin America
                        6.8.1. Brazil
                            6.8.1.1. Key country dynamics
                            6.8.1.2. Regulatory framework/ reimbursement structure
                            6.8.1.3. Competitive scenario
                            6.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
                        6.8.2. Mexico
                            6.8.2.1. Key country dynamics
                            6.8.2.2. Regulatory framework/ reimbursement structure
                            6.8.2.3. Competitive scenario
                            6.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
                        6.8.3. Argentina
                            6.8.3.1. Key country dynamics
                            6.8.3.2. Regulatory framework/ reimbursement structure
                            6.8.3.3. Competitive scenario
                            6.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
                    6.9. MEA
                        6.9.1. South Africa
                            6.9.1.1. Key country dynamics
                            6.9.1.2. Regulatory framework/ reimbursement structure
                            6.9.1.3. Competitive scenario
                            6.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
                        6.9.2. Saudi Arabia
                            6.9.2.1. Key country dynamics
                            6.9.2.2. Regulatory framework/ reimbursement structure
                            6.9.2.3. Competitive scenario
                            6.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
                        6.9.3. UAE
                            6.9.3.1. Key country dynamics
                            6.9.3.2. Regulatory framework/ reimbursement structure
                            6.9.3.3. Competitive scenario
                            6.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
                        6.9.4. Kuwait
                            6.9.4.1. Key country dynamics
                            6.9.4.2. Regulatory framework/ reimbursement structure
                            6.9.4.3. Competitive scenario
                            6.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Competitive Landscape
                    7.1. Recent Developments & Impact Analysis, By Key Market Participants
                    7.2. Company/Competition Categorization
                    7.3. Vendor Landscape
                        7.3.1. List of key distributors and channel partners
                        7.3.2. Key customers
                        7.3.3. Key company market share analysis, 2023
                        7.3.4. SGS S.A.
                            7.3.4.1. Company overview
                            7.3.4.2. Financial performance
                            7.3.4.3. Product benchmarking
                            7.3.4.4. Strategic initiatives
                        7.3.5. Labcorp
                            7.3.5.1. Company overview
                            7.3.5.2. Financial performance
                            7.3.5.3. Product benchmarking
                            7.3.5.4. Strategic initiatives
                        7.3.6. Eurofins Scientific
                            7.3.6.1. Company overview
                            7.3.6.2. Financial performance
                            7.3.6.3. Product benchmarking
                            7.3.6.4. Strategic initiatives
                        7.3.7. Pace Analytical Services, Inc.
                            7.3.7.1. Company overview
                            7.3.7.2. Financial performance
                            7.3.7.3. Product benchmarking
                            7.3.7.4. Strategic initiatives
                        7.3.8. Intertek Group Plc
                            7.3.8.1. Company overview
                            7.3.8.2. Financial performance
                            7.3.8.3. Product benchmarking
                            7.3.8.4. Strategic initiatives
                        7.3.9. PPD Inc. (Thermo Fisher Scientific)
                            7.3.9.1. Company overview
                            7.3.9.2. Financial performance
                            7.3.9.3. Product benchmarking
                            7.3.9.4. Strategic initiatives
                        7.3.10. WuXi AppTec
                            7.3.10.1. Company overview
                            7.3.10.2. Financial performance
                            7.3.10.3. Product benchmarking
                            7.3.10.4. Strategic initiatives
                        7.3.11. Boston Analytical
                            7.3.11.1. Company overview
                            7.3.11.2. Financial performance
                            7.3.11.3. Product benchmarking
                            7.3.11.4. Strategic initiatives
                        7.3.12. Charles River Laboratories
                            7.3.12.1. Company overview
                            7.3.12.2. Financial performance
                            7.3.12.3. Product benchmarking
                            7.3.12.4. Strategic initiatives
                        7.3.13. West Pharmaceutical Services Inc.
                            7.3.13.1. Company overview
                            7.3.13.2. Financial performance
                            7.3.13.3. Product benchmarking
                            7.3.13.4. Strategic initiatives


List of Tables

Table 1 List of abbreviation
Table 2 North America Pharmaceutical Analytical Testing Outsourcing market, by region, 2018 - 2030 (USD Million)
Table 3 North America Pharmaceutical Analytical Testing Outsourcing market, by services, 2018 - 2030 (USD Million)
Table 4 North America Pharmaceutical Analytical Testing Outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 5 U.S. Pharmaceutical Analytical Testing Outsourcing market, by services, 2018 - 2030 (USD Million)
Table 6 U.S. Pharmaceutical Analytical Testing Outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 7 Canada Pharmaceutical Analytical Testing Outsourcing market, by services, 2018 - 2030 (USD Million)
Table 8 Canada Pharmaceutical Analytical Testing Outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 9 Europe Pharmaceutical Analytical Testing Outsourcing market, by region, 2018 - 2030 (USD Million)
Table 10 Europe Pharmaceutical Analytical Testing Outsourcing market, by services, 2018 - 2030 (USD Million)
Table 11 Europe Pharmaceutical Analytical Testing Outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 12 UK Pharmaceutical Analytical Testing Outsourcing market, by services, 2018 - 2030 (USD Million)
Table 13 UK Pharmaceutical Analytical Testing Outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 14 Germany Pharmaceutical Analytical Testing Outsourcing market, by services, 2018 - 2030 (USD Million)
Table 15 Germany Pharmaceutical Analytical Testing Outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 16 France Pharmaceutical Analytical Testing Outsourcing market, by services, 2018 - 2030 (USD Million)
Table 17 France Pharmaceutical Analytical Testing Outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 18 Italy Pharmaceutical Analytical Testing Outsourcing market, by services, 2018 - 2030 (USD Million)
Table 19 Italy Pharmaceutical Analytical Testing Outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 20 Spain Pharmaceutical Analytical Testing Outsourcing market, by services, 2018 - 2030 (USD Million)
Table 21 Spain Pharmaceutical Analytical Testing Outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 22 Denmark Pharmaceutical Analytical Testing Outsourcing market, by services, 2018 - 2030 (USD Million)
Table 23 Denmark Pharmaceutical Analytical Testing Outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 24 Sweden Pharmaceutical Analytical Testing Outsourcing market, by services, 2018 - 2030 (USD Million)
Table 25 Sweden Pharmaceutical Analytical Testing Outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 26 Norway Pharmaceutical Analytical Testing Outsourcing market, by services, 2018 - 2030 (USD Million)
Table 27 Norway Pharmaceutical Analytical Testing Outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 28 Asia Pacific Pharmaceutical Analytical Testing Outsourcing market, by region, 2018 - 2030 (USD Million)
Table 29 Asia Pacific Pharmaceutical Analytical Testing Outsourcing market, by services, 2018 - 2030 (USD Million)
Table 30 Asia Pacific Pharmaceutical Analytical Testing Outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 31 China Pharmaceutical Analytical Testing Outsourcing market, by services, 2018 - 2030 (USD Million)
Table 32 China Pharmaceutical Analytical Testing Outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 33 India Pharmaceutical Analytical Testing Outsourcing market, by services, 2018 - 2030 (USD Million)
Table 34 India Pharmaceutical Analytical Testing Outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 35 Japan Pharmaceutical Analytical Testing Outsourcing market, by services, 2018 - 2030 (USD Million)
Table 36 Japan Pharmaceutical Analytical Testing Outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 37 Australia Pharmaceutical Analytical Testing Outsourcing market, by services, 2018 - 2030 (USD Million)
Table 38 Australia Pharmaceutical Analytical Testing Outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 39 South Korea Pharmaceutical Analytical Testing Outsourcing market, by services, 2018 - 2030 (USD Million)
Table 40 South Korea Pharmaceutical Analytical Testing Outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 41 Thailand Pharmaceutical Analytical Testing Outsourcing market, by services, 2018 - 2030 (USD Million)
Table 42 Thailand Pharmaceutical Analytical Testing Outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 43 Latin America Pharmaceutical Analytical Testing Outsourcing market, by region, 2018 - 2030 (USD Million)
Table 44 Latin America Pharmaceutical Analytical Testing Outsourcing market, by services, 2018 - 2030 (USD Million)
Table 45 Latin America Pharmaceutical Analytical Testing Outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 46 Brazil Pharmaceutical Analytical Testing Outsourcing market, by services, 2018 - 2030 (USD Million)
Table 47 Brazil Pharmaceutical Analytical Testing Outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 48 Mexico Pharmaceutical Analytical Testing Outsourcing market, by services, 2018 - 2030 (USD Million)
Table 49 Mexico Pharmaceutical Analytical Testing Outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 50 Argentina Pharmaceutical Analytical Testing Outsourcing market, by services, 2018 - 2030 (USD Million)
Table 51 Argentina Pharmaceutical Analytical Testing Outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 52 MEA Pharmaceutical Analytical Testing Outsourcing market, by region, 2018 - 2030 (USD Million)
Table 53 MEA Pharmaceutical Analytical Testing Outsourcing market, by services, 2018 - 2030 (USD Million)
Table 54 MEA Pharmaceutical Analytical Testing Outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 55 South Africa Pharmaceutical Analytical Testing Outsourcing market, by services, 2018 - 2030 (USD Million)
Table 56 South Africa Pharmaceutical Analytical Testing Outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 57 Saudi Arabia Pharmaceutical Analytical Testing Outsourcing market, by services, 2018 - 2030 (USD Million)
Table 58 Saudi Arabia Pharmaceutical Analytical Testing Outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 59 UAE Pharmaceutical Analytical Testing Outsourcing market, by services, 2018 - 2030 (USD Million)
Table 60 UAE Pharmaceutical Analytical Testing Outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 61 Kuwait Pharmaceutical Analytical Testing Outsourcing market, by services, 2018 - 2030 (USD Million)
Table 62 Kuwait Pharmaceutical Analytical Testing Outsourcing market, by end use, 2018 - 2030 (USD Million)


List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Pharmaceutical Analytical Testing Outsourcing market: market outlook
Fig. 14 Pharmaceutical Analytical Testing Outsourcing competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Pharmaceutical Analytical Testing Outsourcing market driver impact
Fig. 20 Pharmaceutical Analytical Testing Outsourcing market restraint impact
Fig. 21 Pharmaceutical Analytical Testing Outsourcing market strategic initiatives analysis
Fig. 22 Pharmaceutical Analytical Testing Outsourcing market: Services movement analysis
Fig. 23 Pharmaceutical Analytical Testing Outsourcing market: Services outlook and key takeaways
Fig. 24 Bioanalytical Testing market estimates and forecast, 2018- 2030
Fig. 25 Clinical market estimates and forecast, 2018- 2030
Fig. 26 Non-clinical market estimates and forecast, 2018- 2030
Fig. 27 Method Development & Validation market estimates and forecast, 2018- 2030
Fig. 28 Extractable & Leachable market estimates and forecast, 2018- 2030
Fig. 29 Impurity Method market estimates and forecast, 2018- 2030
Fig. 30 Technical Consulting market estimates and forecast, 2018- 2030
Fig. 31 Others market estimates and forecast, 2018- 2030
Fig. 32 Stability Testing market estimates and forecast, 2018- 2030
Fig. 33 Drug Substance market estimates and forecast, 2018- 2030
Fig. 34 Stability Indicating Method Validation market estimates and forecast, 2018- 2030
Fig. 35 Accelerated Stability Testing market estimates and forecast, 2018- 2030
Fig. 36 Photostability Testing market estimates and forecast, 2018- 2030
Fig. 37 Others market estimates and forecast, 2018- 2030
Fig. 38 Others market estimates and forecast, 2018- 2030
Fig. 39 Pharmaceutical Analytical Testing Outsourcing Market: End-use movement Analysis
Fig. 40 Pharmaceutical Analytical Testing Outsourcing market: End-use outlook and key takeaways
Fig. 41 Pharmaceutical Companies market estimates and forecasts, 2018- 2030
Fig. 42 Biopharmaceutical Companies market estimates and forecasts, 2018- 2030
Fig. 43 Contract Research Organizations market estimates and forecasts, 2018- 2030
Fig. 44 Global Pharmaceutical Analytical Testing Outsourcing market: Regional movement analysis
Fig. 45 Global Pharmaceutical Analytical Testing Outsourcing market: Regional outlook and key takeaways
Fig. 46 Global Pharmaceutical Analytical Testing Outsourcing market share and leading players
Fig. 47 North America market share and leading players
Fig. 48 Europe market share and leading players
Fig. 49 Asia Pacific market share and leading players
Fig. 50 Latin America market share and leading players
Fig. 51 Middle East & Africa market share and leading players
Fig. 52 North America: SWOT
Fig. 53 Europe SWOT
Fig. 54 Asia Pacific SWOT
Fig. 55 Latin America SWOT
Fig. 56 MEA SWOT
Fig. 57 North America, by country
Fig. 58 North America
Fig. 59 North America market estimates and forecasts, 2018- 2030
Fig. 60 U.S.
Fig. 61 U.S. market estimates and forecasts, 2018- 2030
Fig. 62 Canada
Fig. 63 Canada market estimates and forecasts, 2018- 2030
Fig. 64 Europe
Fig. 65 Europe market estimates and forecasts, 2018- 2030
Fig. 66 UK
Fig. 67 UK market estimates and forecasts, 2018- 2030
Fig. 68 Germany
Fig. 69 Germany market estimates and forecasts, 2018- 2030
Fig. 70 France
Fig. 71 France market estimates and forecasts, 2018- 2030
Fig. 72 Italy
Fig. 73 Italy market estimates and forecasts, 2018- 2030
Fig. 74 Spain
Fig. 75 Spain market estimates and forecasts, 2018- 2030
Fig. 76 Denmark
Fig. 77 Denmark market estimates and forecasts, 2018- 2030
Fig. 78 Sweden
Fig. 79 Sweden market estimates and forecasts, 2018- 2030
Fig. 80 Norway
Fig. 81 Norway market estimates and forecasts, 2018- 2030
Fig. 82 Asia Pacific
Fig. 83 Asia Pacific market estimates and forecasts, 2018- 2030
Fig. 84 China
Fig. 85 China market estimates and forecasts, 2018- 2030
Fig. 86 Japan
Fig. 87 Japan market estimates and forecasts, 2018- 2030
Fig. 88 India
Fig. 89 India market estimates and forecasts, 2018- 2030
Fig. 90 Thailand
Fig. 91 Thailand market estimates and forecasts, 2018- 2030
Fig. 92 South Korea
Fig. 93 South Korea market estimates and forecasts, 2018- 2030
Fig. 94 Australia
Fig. 95 Australia market estimates and forecasts, 2018- 2030
Fig. 96 Latin America
Fig. 97 Latin America market estimates and forecasts, 2018- 2030
Fig. 98 Brazil
Fig. 99 Brazil market estimates and forecasts, 2018- 2030
Fig. 100 Mexico
Fig. 101 Mexico market estimates and forecasts, 2018- 2030
Fig. 102 Argentina
Fig. 103 Argentina market estimates and forecasts, 2018- 2030
Fig. 104 Middle East and Africa
Fig. 105 Middle East and Africa market estimates and forecasts, 2018- 2030
Fig. 106 South Africa
Fig. 107 South Africa market estimates and forecasts, 2018- 2030
Fig. 108 Saudi Arabia
Fig. 109 Saudi Arabia market estimates and forecasts, 2018- 2030
Fig. 110 UAE
Fig. 111 UAE market estimates and forecasts, 2018- 2030
Fig. 112 Kuwait
Fig. 113 Kuwait market estimates and forecasts, 2018- 2030
Fig. 114 Market share of key market players- Pharmaceutical Analytical Testing Outsourcing market

What questions do you have? Get quick response from our industry experts. Request a Free Consultation

Market Segmentation

  • Pharmaceutical Analytical Testing Outsourcing Service Outlook (Revenue, USD Million, 2018 - 2030)
    • Bioanalytical Testing
      • Clinical
      • Non-Clinical
    • Method Development & Validation
      • Extractable & Leachable
      • Impurity Method
      • Technical Consulting
      • Others
    • Stability Testing
      • Drug Substance
      • Stability Indicating Method Validation
      • Accelerated Stability Testing
      • Photostability Testing
      • Others
    • Others
  • Pharmaceutical Analytical Testing Outsourcing End-use Outlook (Revenue, USD Million, 2018 - 2030)
    • Pharmaceutical Companies
    • Biopharmaceutical Companies
    • Contract Research Organizations
  • Pharmaceutical Analytical Testing Outsourcing Regional Outlook (Revenue, USD Million, 2018 - 2030)
    • North America
      • North America Pharmaceutical analytical testing outsourcing market, By Services
        • Bioanalytical Testing
          • Clinical
          • Non-Clinical
        • Method Development & Validation
          • Extractable & Leachable
          • Impurity Method
          • Technical Consulting
          • Others
        • Stability Testing
          • Drug Substance
          • Stability Indicating Method Validation
          • Accelerated Stability Testing
          • Photostability Testing
          • Others
        • Others
      • North America Pharmaceutical analytical testing outsourcing market, By End-use
        • Pharmaceutical Companies
        • Biopharmaceutical Companies
        • Contract Research Organizations
      • U.S.
        • U.S. Pharmaceutical analytical testing outsourcing market, By Services
          • Bioanalytical Testing
            • Clinical
            • Non-Clinical
          • Method Development & Validation
            • Extractable & Leachable
            • Impurity Method
            • Technical Consulting
            • Others
          • Stability Testing
            • Drug Substance
            • Stability Indicating Method Validation
            • Accelerated Stability Testing
            • Photostability Testing
            • Others
          • Others
        • U.S. Pharmaceutical analytical testing outsourcing market, By End-use
          • Pharmaceutical Companies
          • Biopharmaceutical Companies
          • Contract Research Organizations
      • Canada
        • Canada Pharmaceutical analytical testing outsourcing market, By Services
          • Bioanalytical Testing
            • Clinical
            • Non-Clinical
          • Method Development & Validation
            • Extractable & Leachable
            • Impurity Method
            • Technical Consulting
            • Others
          • Stability Testing
            • Drug Substance
            • Stability Indicating Method Validation
            • Accelerated Stability Testing
            • Photostability Testing
            • Others
          • Others
        • Canada Pharmaceutical analytical testing outsourcing market, By End-use
          • Pharmaceutical Companies
          • Biopharmaceutical Companies
          • Contract Research Organizations
    • Europe
      • Europe Pharmaceutical analytical testing outsourcing market, By Services
        • Bioanalytical Testing
          • Clinical
          • Non-Clinical
        • Method Development & Validation
          • Extractable & Leachable
          • Impurity Method
          • Technical Consulting
          • Others
        • Stability Testing
          • Drug Substance
          • Stability Indicating Method Validation
          • Accelerated Stability Testing
          • Photostability Testing
          • Others
        • Others
      • Europe Pharmaceutical analytical testing outsourcing market, By End-use
        • Pharmaceutical Companies
        • Biopharmaceutical Companies
        • Contract Research Organizations
      • U.K.
        • U.K. Pharmaceutical analytical testing outsourcing market, By Services
          • Bioanalytical Testing
            • Clinical
            • Non-Clinical
          • Method Development & Validation
            • Extractable & Leachable
            • Impurity Method
            • Technical Consulting
            • Others
          • Stability Testing
            • Drug Substance
            • Stability Indicating Method Validation
            • Accelerated Stability Testing
            • Photostability Testing
            • Others
          • Others
        • U.K. Pharmaceutical analytical testing outsourcing market, By End-use
          • Pharmaceutical Companies
          • Biopharmaceutical Companies
          • Contract Research Organizations
      • Germany
        • Germany Pharmaceutical analytical testing outsourcing market, By Services
          • Bioanalytical Testing
            • Clinical
            • Non-Clinical
          • Method Development & Validation
            • Extractable & Leachable
            • Impurity Method
            • Technical Consulting
            • Others
          • Stability Testing
            • Drug Substance
            • Stability Indicating Method Validation
            • Accelerated Stability Testing
            • Photostability Testing
            • Others
          • Others
        • Germany Pharmaceutical analytical testing outsourcing market, By End-use
          • Pharmaceutical Companies
          • Biopharmaceutical Companies
          • Contract Research Organizations
      • France
        • France Pharmaceutical analytical testing outsourcing market, By Services
          • Bioanalytical Testing
            • Clinical
            • Non-Clinical
          • Method Development & Validation
            • Extractable & Leachable
            • Impurity Method
            • Technical Consulting
            • Others
          • Stability Testing
            • Drug Substance
            • Stability Indicating Method Validation
            • Accelerated Stability Testing
            • Photostability Testing
            • Others
          • Others
        • France Pharmaceutical analytical testing outsourcing market, By End-use
          • Pharmaceutical Companies
          • Biopharmaceutical Companies
          • Contract Research Organizations
      • Italy
        • Italy Pharmaceutical analytical testing outsourcing market, By Services
          • Bioanalytical Testing
            • Clinical
            • Non-Clinical
          • Method Development & Validation
            • Extractable & Leachable
            • Impurity Method
            • Technical Consulting
            • Others
          • Stability Testing
            • Drug Substance
            • Stability Indicating Method Validation
            • Accelerated Stability Testing
            • Photostability Testing
            • Others
          • Others
        • Italy Pharmaceutical analytical testing outsourcing market, By End-use
          • Pharmaceutical Companies
          • Biopharmaceutical Companies
          • Contract Research Organizations
      • Spain
        • Spain Pharmaceutical analytical testing outsourcing market, By Services
          • Bioanalytical Testing
            • Clinical
            • Non-Clinical
          • Method Development & Validation
            • Extractable & Leachable
            • Impurity Method
            • Technical Consulting
            • Others
          • Stability Testing
            • Drug Substance
            • Stability Indicating Method Validation
            • Accelerated Stability Testing
            • Photostability Testing
            • Others
          • Others
        • Spain Pharmaceutical analytical testing outsourcing market, By End-use
          • Pharmaceutical Companies
          • Biopharmaceutical Companies
          • Contract Research Organizations
      • Denmark
        • Denmark Pharmaceutical analytical testing outsourcing market, By Services
          • Bioanalytical Testing
            • Clinical
            • Non-Clinical
          • Method Development & Validation
            • Extractable & Leachable
            • Impurity Method
            • Technical Consulting
            • Others
          • Stability Testing
            • Drug Substance
            • Stability Indicating Method Validation
            • Accelerated Stability Testing
            • Photostability Testing
            • Others
          • Others
        • Denmark Pharmaceutical analytical testing outsourcing market, By End-use
          • Pharmaceutical Companies
          • Biopharmaceutical Companies
          • Contract Research Organizations
      • Sweden
        • Sweden Pharmaceutical analytical testing outsourcing market, By Services
          • Bioanalytical Testing
            • Clinical
            • Non-Clinical
          • Method Development & Validation
            • Extractable & Leachable
            • Impurity Method
            • Technical Consulting
            • Others
          • Stability Testing
            • Drug Substance
            • Stability Indicating Method Validation
            • Accelerated Stability Testing
            • Photostability Testing
            • Others
          • Others
        • Sweden Pharmaceutical analytical testing outsourcing market, By End-use
          • Pharmaceutical Companies
          • Biopharmaceutical Companies
          • Contract Research Organizations
      • Norway
        • Norway Pharmaceutical analytical testing outsourcing market, By Services
          • Bioanalytical Testing
            • Clinical
            • Non-Clinical
          • Method Development & Validation
            • Extractable & Leachable
            • Impurity Method
            • Technical Consulting
            • Others
          • Stability Testing
            • Drug Substance
            • Stability Indicating Method Validation
            • Accelerated Stability Testing
            • Photostability Testing
            • Others
          • Others
        • Norway Pharmaceutical analytical testing outsourcing market, By End-use
          • Pharmaceutical Companies
          • Biopharmaceutical Companies
          • Contract Research Organizations
    • Asia Pacific
      • Asia Pacific Pharmaceutical analytical testing outsourcing market, By Services
        • Bioanalytical Testing
          • Clinical
          • Non-Clinical
        • Method Development & Validation
          • Extractable & Leachable
          • Impurity Method
          • Technical Consulting
          • Others
        • Stability Testing
          • Drug Substance
          • Stability Indicating Method Validation
          • Accelerated Stability Testing
          • Photostability Testing
          • Others
        • Others
      • Asia Pacific Pharmaceutical analytical testing outsourcing market, By End-use
        • Pharmaceutical Companies
        • Biopharmaceutical Companies
        • Contract Research Organizations
      • Japan
        • Japan Pharmaceutical analytical testing outsourcing market, By Services
          • Bioanalytical Testing
            • Clinical
            • Non-Clinical
          • Method Development & Validation
            • Extractable & Leachable
            • Impurity Method
            • Technical Consulting
            • Others
          • Stability Testing
            • Drug Substance
            • Stability Indicating Method Validation
            • Accelerated Stability Testing
            • Photostability Testing
            • Others
          • Others
        • Japan Pharmaceutical analytical testing outsourcing market, By End-use
          • Pharmaceutical Companies
          • Biopharmaceutical Companies
          • Contract Research Organizations
      • China
        • China Pharmaceutical analytical testing outsourcing market, By Services
          • Bioanalytical Testing
            • Clinical
            • Non-Clinical
          • Method Development & Validation
            • Extractable & Leachable
            • Impurity Method
            • Technical Consulting
            • Others
          • Stability Testing
            • Drug Substance
            • Stability Indicating Method Validation
            • Accelerated Stability Testing
            • Photostability Testing
            • Others
          • Others
        • China Pharmaceutical analytical testing outsourcing market, By End-use
          • Pharmaceutical Companies
          • Biopharmaceutical Companies
          • Contract Research Organizations
      • India
        • India Pharmaceutical analytical testing outsourcing market, By Services
          • Bioanalytical Testing
            • Clinical
            • Non-Clinical
          • Method Development & Validation
            • Extractable & Leachable
            • Impurity Method
            • Technical Consulting
            • Others
          • Stability Testing
            • Drug Substance
            • Stability Indicating Method Validation
            • Accelerated Stability Testing
            • Photostability Testing
            • Others
          • Others
        • India Pharmaceutical analytical testing outsourcing market, By End-use
          • Pharmaceutical Companies
          • Biopharmaceutical Companies
          • Contract Research Organizations
      • Australia
        • Australia Pharmaceutical analytical testing outsourcing market, By Services
          • Bioanalytical Testing
            • Clinical
            • Non-Clinical
          • Method Development & Validation
            • Extractable & Leachable
            • Impurity Method
            • Technical Consulting
            • Others
          • Stability Testing
            • Drug Substance
            • Stability Indicating Method Validation
            • Accelerated Stability Testing
            • Photostability Testing
            • Others
          • Others
        • Australia Pharmaceutical analytical testing outsourcing market, By End-use
          • Pharmaceutical Companies
          • Biopharmaceutical Companies
          • Contract Research Organizations
      • South Korea
        • South Korea Pharmaceutical analytical testing outsourcing market, By Services
          • Bioanalytical Testing
            • Clinical
            • Non-Clinical
          • Method Development & Validation
            • Extractable & Leachable
            • Impurity Method
            • Technical Consulting
            • Others
          • Stability Testing
            • Drug Substance
            • Stability Indicating Method Validation
            • Accelerated Stability Testing
            • Photostability Testing
            • Others
          • Others
        • South Korea Pharmaceutical analytical testing outsourcing market, By End-use
          • Pharmaceutical Companies
          • Biopharmaceutical Companies
          • Contract Research Organizations
      • Thailand
        • Thailand Pharmaceutical analytical testing outsourcing market, By Services
          • Bioanalytical Testing
            • Clinical
            • Non-Clinical
          • Method Development & Validation
            • Extractable & Leachable
            • Impurity Method
            • Technical Consulting
            • Others
          • Stability Testing
            • Drug Substance
            • Stability Indicating Method Validation
            • Accelerated Stability Testing
            • Photostability Testing
            • Others
          • Others
        • Thailand Pharmaceutical analytical testing outsourcing market, By End-use
          • Pharmaceutical Companies
          • Biopharmaceutical Companies
          • Contract Research Organizations
    • Latin America
      • Latin America Pharmaceutical analytical testing outsourcing market, By Services
        • Bioanalytical Testing
          • Clinical
          • Non-Clinical
        • Method Development & Validation
          • Extractable & Leachable
          • Impurity Method
          • Technical Consulting
          • Others
        • Stability Testing
          • Drug Substance
          • Stability Indicating Method Validation
          • Accelerated Stability Testing
          • Photostability Testing
          • Others
        • Others
      • Latin America Pharmaceutical analytical testing outsourcing market, By End-use
        • Pharmaceutical Companies
        • Biopharmaceutical Companies
        • Contract Research Organizations
      • Brazil
        • Brazil Pharmaceutical analytical testing outsourcing market, By Services
          • Bioanalytical Testing
            • Clinical
            • Non-Clinical
          • Method Development & Validation
            • Extractable & Leachable
            • Impurity Method
            • Technical Consulting
            • Others
          • Stability Testing
            • Drug Substance
            • Stability Indicating Method Validation
            • Accelerated Stability Testing
            • Photostability Testing
            • Others
          • Others
        • Brazil Pharmaceutical analytical testing outsourcing market, By End-use
          • Pharmaceutical Companies
          • Biopharmaceutical Companies
          • Contract Research Organizations
      • Mexico
        • Mexico Pharmaceutical analytical testing outsourcing market, By Services
          • Bioanalytical Testing
            • Clinical
            • Non-Clinical
          • Method Development & Validation
            • Extractable & Leachable
            • Impurity Method
            • Technical Consulting
            • Others
          • Stability Testing
            • Drug Substance
            • Stability Indicating Method Validation
            • Accelerated Stability Testing
            • Photostability Testing
            • Others
          • Others
        • Mexico Pharmaceutical analytical testing outsourcing market, By End-use
          • Pharmaceutical Companies
          • Biopharmaceutical Companies
          • Contract Research Organizations
      • Argentina
        • Argentina Pharmaceutical analytical testing outsourcing market, By Services
          • Bioanalytical Testing
            • Clinical
            • Non-Clinical
          • Method Development & Validation
            • Extractable & Leachable
            • Impurity Method
            • Technical Consulting
            • Others
          • Stability Testing
            • Drug Substance
            • Stability Indicating Method Validation
            • Accelerated Stability Testing
            • Photostability Testing
            • Others
          • Others
        • Argentina Pharmaceutical analytical testing outsourcing market, By End-use
          • Pharmaceutical Companies
          • Biopharmaceutical Companies
          • Contract Research Organizations
    • MEA
      • MEA Pharmaceutical analytical testing outsourcing market, By Services
        • Bioanalytical Testing
          • Clinical
          • Non-Clinical
        • Method Development & Validation
          • Extractable & Leachable
          • Impurity Method
          • Technical Consulting
          • Others
        • Stability Testing
          • Drug Substance
          • Stability Indicating Method Validation
          • Accelerated Stability Testing
          • Photostability Testing
          • Others
        • Others
      • MEA Pharmaceutical analytical testing outsourcing market, By End-use
        • Pharmaceutical Companies
        • Biopharmaceutical Companies
        • Contract Research Organizations
      • South Africa
        • South Africa Pharmaceutical analytical testing outsourcing market, By Services
          • Bioanalytical Testing
            • Clinical
            • Non-Clinical
          • Method Development & Validation
            • Extractable & Leachable
            • Impurity Method
            • Technical Consulting
            • Others
          • Stability Testing
            • Drug Substance
            • Stability Indicating Method Validation
            • Accelerated Stability Testing
            • Photostability Testing
            • Others
          • Others
        • South Africa Pharmaceutical analytical testing outsourcing market, By End-use
          • Pharmaceutical Companies
          • Biopharmaceutical Companies
          • Contract Research Organizations
      • Saudi Arabia
        • Saudi Arabia Pharmaceutical analytical testing outsourcing market, By Services
          • Bioanalytical Testing
            • Clinical
            • Non-Clinical
          • Method Development & Validation
            • Extractable & Leachable
            • Impurity Method
            • Technical Consulting
            • Others
          • Stability Testing
            • Drug Substance
            • Stability Indicating Method Validation
            • Accelerated Stability Testing
            • Photostability Testing
            • Others
          • Others
        • Saudi Arabia Pharmaceutical analytical testing outsourcing market, By End-use
          • Pharmaceutical Companies
          • Biopharmaceutical Companies
          • Contract Research Organizations
      • UAE
        • UAE Pharmaceutical analytical testing outsourcing market, By Services
          • Bioanalytical Testing
            • Clinical
            • Non-Clinical
          • Method Development & Validation
            • Extractable & Leachable
            • Impurity Method
            • Technical Consulting
            • Others
          • Stability Testing
            • Drug Substance
            • Stability Indicating Method Validation
            • Accelerated Stability Testing
            • Photostability Testing
            • Others
          • Others
        • UAE Pharmaceutical analytical testing outsourcing market, By End-use
          • Pharmaceutical Companies
          • Biopharmaceutical Companies
          • Contract Research Organizations
      • Kuwait
        • Kuwait Pharmaceutical analytical testing outsourcing market, By Services
          • Bioanalytical Testing
            • Clinical
            • Non-Clinical
          • Method Development & Validation
            • Extractable & Leachable
            • Impurity Method
            • Technical Consulting
            • Others
          • Stability Testing
            • Drug Substance
            • Stability Indicating Method Validation
            • Accelerated Stability Testing
            • Photostability Testing
            • Others
          • Others
        • Kuwait Pharmaceutical analytical testing outsourcing market, By End-use
          • Pharmaceutical Companies
          • Biopharmaceutical Companies
          • Contract Research Organizations

Pharmaceutical Analytical Testing Outsourcing Market Dynamics

Driver: Increasing pace of innovations and product development

Innovation and new product development is directly related to the demand for testing services. Due to competitive pressures, pricing concerns, and lead-time to market, companies are preferring outsourcing of testing services. Increasing focus on customized care and technological advancements have reduced the product lifecycle, leading to rapid development of new products. Development of biosimilars, combination products, and other innovative medicines has led to increased demand for specific test types. Moreover, when companies expand their business to a new location, it is mandatory to follow local standards, which may require them to conduct particular types of tests. Outsourcing companies are helping in strategizing systematic approaches to simplify the automation required in analytical instruments. It also increases the speed to market products along with innovative thinking.

Moreover, the use of automation technology has also helped in the development of new drugs by expediting the process without affecting drug quality. In this process, data recording is performed and everything in an experiment is recorded so that the experiment is accurate & repeatable. The use of new technologies has also become fast and they help in organizing & saving data. Increasing R&D investments is a critical sustainability strategy. Not all companies have an infrastructure compatible for all types of analytical testing. Hence, outsourcing these operations is the most suitable option, which also helps save time and costs. In recent years, the R&D expense to total revenue ratio is increasing and expected to continue to rise through 2030.

Driver: Growing safety and quality regulation demand

Increase in complexity and number of standards, which a single product may have to comply with, is driving strong growth in the pharmaceutical analytical testing services outsourcing industry. In addition, companies are required to stay updated with regulatory guidelines and avail expertise & advisory services to be in synchronization with evolving standards. Moreover, organizations such as the International Council for Harmonization (ICH) give harmonized guidelines that are regularly updated. These guidelines are provided so that proper testing, application, and safety of the pharmaceutical product is performed before approving it for human use.

Stringent regulations issued by global regulatory authorities, such as FDA guidelines for clinical trials during the COVID-19 outbreak, Clinical Laboratory Improvement Amendments (CLIA) laboratory regulations, and Good Laboratory Practice (GLP) laboratory regulation, along with increased demand for developing safe & effective therapies and vaccines against SARS-CoV-2, are anticipated to increase the scrutiny on laboratory testing. Testing regulations in Australia are handled by National Measurement Institute (NMI) pertaining to pharmaceutical analysis services, which helps manufacturers in attaining the desired safety level that is appropriate for human use. Increasing awareness about product quality, environmental issues, and safety among consumers is driving companies to outsource tests to ensure that the product complies with aforementioned aspects, thereby building a brand image and enhancing its reputation.

Restraint: Lack of data security

There is always a bilateral information exchange between the client and analytical testing firm involved in the process of analytical testing outsourcing. Several times, clients may have to share confidential information with testing firms, which entails a threat of misuse of this confidential information. If there is no legitimate contract about information security and privacy, it may lead to discrepancies among both parties, hampering mutual trust. For instance, the consultant’s brand image may get affected or the client may have to compromise on security of confidential data.

The attack on data disturbs the process and also delays drug development process. The shared data is very sensitive and can put lives at risk. This data has to be protected effectively, which can be achieved by implementing strong network security. However, this cannot be relied on alone, so there is a need to understand the risks and vulnerabilities within as well as of third-party sources that will help in building resilient data security that would be difficult to breach. Many multinational and small pharmaceutical players are hesitant to opt for consulting services due to the fear of breach of secure information. However, in the future, this situation is expected to change as consulting firms are proactively undertaking initiatives for information protection.

What Does This Report Include?

This section will provide insights into the contents included in this pharmaceutical analytic testing outsourcing market report and help gain clarity on the structure of the report to assist readers in navigating smoothly.

Pharmaceutical analytical testing outsourcing market qualitative analysis

  • Industry overview

  • Industry trends

  • Market drivers and restraints

  • Market size

  • Growth prospects

  • Porter’s analysis

  • PESTEL analysis

  • Key market opportunities prioritized

  • Competitive landscape

    • Company overview

    • Financial performance

    • Product benchmarking

    • Latest strategic developments

Pharmaceutical analytical testing outsourcing market quantitative analysis

  • Market size, estimates, and forecast from 2018 to 2030

  • Market estimates and forecast for product segments up to 2030

  • Regional market size and forecast for product segments up to 2030

  • Market estimates and forecast for application segments up to 2030

  • Regional market size and forecast for application segments up to 2030

  • Company financial performance

What questions do you have? Get quick response from our industry experts. Request a Free Consultation

Research Methodology

A three-pronged approach was followed for deducing the pharmaceutical analytical testing outsourcing market estimates and forecasts. The process has three steps: information procurement, analysis, and validation. The whole process is cyclical, and steps repeat until the estimates are validated. The three steps are explained in detail below:

Information procurement: Information procurement is one of the most extensive and important stages in our research process, and quality data is critical for accurate analysis. We followed a multi-channel data collection process for pharmaceutical analytical testing outsourcing market to gather the most reliable and current information possible.

  • We buy access to paid databases such as Hoover’s and Factiva for company financials, industry information, white papers, industry journals, SME journals, and more.
  • We tap into Grand View’s proprietary database of data points and insights from active and archived monitoring and reporting.
  • We conduct primary research with industry experts through questionnaires and one-on-one phone interviews.
  • We pull from reliable secondary sources such as white papers and government statistics, published by organizations like WHO, NGOs, World Bank, etc., Key Opinion Leaders (KoL) publications, company filings, investor documents, and more.
  • We purchase and review investor analyst reports, broker reports, academic commentary, government quotes, and wealth management publications for insightful third-party perspectives.

Analysis: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilized different methods of pharmaceutical analytical testing outsourcing market data depending on the type of information we’re trying to uncover in our research.

  • Market Research Efforts: Bottom-up Approach for estimating and forecasting demand size and opportunity, top-down Approach for new product forecasting and penetration, and combined approach of both Bottom-up and Top-down for full coverage analysis.

  • Value-Chain-Based Sizing & Forecasting: Supply-side estimates for understanding potential revenue through competitive benchmarking, forecasting, and penetration modeling.

  • Demand-side estimates for identifying parent and ancillary markets, segment modeling, and heuristic forecasting.

  • Qualitative Functional Deployment (QFD) Modelling for market share assessment.

Market formulation and validation: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilize different methods of data analysis depending on the type of information we’re trying to uncover in our research.

  • Market Formulation: This step involves the finalization of market numbers. This step on an internal level is designed to manage outputs from the Data Analysis step.

  • Data Normalization: The final market estimates and forecasts are then aligned and sent to industry experts, in-panel quality control managers for validation.

  • This step also entails the finalization of the report scope and data representation pattern.

  • Validation: The process entails multiple levels of validation. All these steps run in parallel, and the study is forwarded for publishing only if all three levels render validated results.

Pharmaceutical Analytical Testing Outsourcing Market Categorization:

The pharmaceutical analytical testing outsourcing market was categorized into three segments, namely service (Bioanalytical Testing, Method Development & Validation, Stability Testing), end-use (Pharmaceutical Companies, Biopharmaceutical Companies, Contract Research Organizations), and region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa).

Segment Market Methodology:

The pharmaceutical analytical testing outsourcing market was segmented into service, end-use, and regions. The demand at a segment level was deduced using a funnel method. Concepts like the TAM, SAM, SOM, etc., were put into practice to understand the demand. We at GVR deploy three methods to deduce market estimates and determine forecasts. These methods are explained below:

Market research approaches: Bottom-up

  • Demand estimation of each product across countries/regions summed up to from the total market.

  • Variable analysis for demand forecast.

  • Demand estimation via analyzing paid database, and company financials either via annual reports or paid database.

  • Primary interviews for data revalidation and insight collection.

Market research approaches: Top-down

  • Used extensively for new product forecasting or analyzing penetration levels.

  • Tool used invoice product flow and penetration models Use of regression multi-variant analysis for forecasting Involves extensive use of paid and public databases.

  • Primary interviews and vendor-based primary research for variable impact analysis.

Market research approaches: Combined

  • This is the most common method. We apply concepts from both the top-down and bottom-up approaches to arrive at a viable conclusion.

Regional Market Methodology:

The pharmaceutical analytical testing outsourcing market was analyzed at a regional level. The globe was divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, keeping in focus variables like consumption patterns, export-import regulations, consumer expectations, etc. These regions were further divided into thirty-two countries, namely, the U.S.; Canada; the UK; Germany; France; Italy; Spain; Russia; Netherlands; Switzerland; Turkey; Sweden; Japan; China; India; Australia; South Korea; Indonesia; Malaysia; Singapore; Thailand; Taiwan; Brazil; Mexico; Argentina; Colombia; Chile; South Africa; Saudi Arabia; UAE; Egypt; Israel.

All three above-mentioned market research methodologies were applied to arrive at regional-level conclusions. The regions were then summed up to form the global market.

Pharmaceutical analytical testing outsourcing market companies & financials:

The pharmaceutical analytical testing outsourcing market was analyzed via companies operating in the sector. Analyzing these companies and cross-referencing them to the demand equation helped us validate our assumptions and conclusions. Key market players analyzed include:

  • SGS SA offers inspection, testing, certification, and verification services for various industries. It operates in chemicals, consumer & retail goods, agriculture & food, construction, life sciences, energy, industrial manufacturing, logistics, oil & gas, public sector, mining, and transportation. For life sciences, the company caters to the following verticals: clinical research services, laboratory services, biopharmaceutical services, medical devices, pharmaceutical services, health & wellness, quality health safety & environment, and technical staffing services. The company has over 2,600 offices and laboratories globally.

  • Laboratory Corporation of America Holdings (LabCorp) was created in 1995 post the merger of National Health Laboratory Holdings, Inc. and Roche Biomedical Laboratories, Inc. It is involved in the development of drugs and diagnostics. The company serves clients across 100 countries. Its clients include hospitals, physicians, employers, governmental agencies, and other independent clinical laboratories. It has clinical laboratories that are located in the U.S. and other countries, including Canada, the UK, and UAE.

  • Eurofins Scientific SE (Eurofins) is the provider of analytical testing services across the globe. Eurofins has a portfolio of 150,000 analytical methods for the evaluation of composition, authenticity, and purity of biological substances. It also provides agro-testing, environment testing, consumer product testing, medical device testing, and chemical registration & authorization services. Eurofins cater its portfolio of services to pharmaceutical, consumer product, food, and environment with a network of more than 900 laboratories in 54 economies.

  • Pace Analytical Services, Inc. is a sampling and analytical testing services company and operates as a subsidiary of LAB Holdings, Inc. It offers chemistry services, such as method development, validation, verification, and method transfer services, including raw material testing, extractable & leachable testing, quality testing, residual solvents testing, environment monitoring, impurities testing, and microbiology laboratory testing. Pace also provides other services such as scientific staffing, instrument sale & services, and consulting. It offers its services through a network of analytical labs and service centers in the U.S. The company has over 500 certifications.

  • Intertek Group plc (IGP) provides quality and safety solutions and operates through three reportable segments: Product, Trade, and Resources. The product segment’s key offerings include inspection & certification services, laboratory testing, quality & performance testing, supplier auditing, vendor compliance, and sustainability analysis. Its trade and resources segment offers technical services, analytical testing services, calibration, and asset integrity services. IGP caters to life science, food, pharmaceuticals, and healthcare industries. It has presence in 1,000 locations in over 100 countries.

  • Pharmaceutical Product Development, LLC (PPD) provides drug discovery & development and post-approval services as well as compound partnering programs. The company caters to pharmaceuticals, medical device companies, biotechnology institutions, government organizations, and academic institutions. In December 2011, Carlyle Group in affiliation with Hellman & Friedman acquired PPD for USD 3.9 billion. Key therapeutic areas in which the company offers services include cardiology, critical care, dermatology, hematology, oncology, pulmonology, and urology.

  • WuXi AppTec, Inc. (WAI) is a provider of contract research & development outsourcing services for medical device, biotechnology, and pharmaceutical companies. Its pharmaceutical services include safety pharmacology, pharmacokinetics, bioanalysis, drug metabolism, and medicinal & analytical chemistry. WAI also offers biocompatibility testing, preclinical services, toxicology testing, package & validation testing, genetic toxicology, and material characterization services. It operates as a subsidiary of WuXi PharmaTech (Cayman) Inc. WAI has a strategic collaboration with REGENXBIO, Inc. & MedImmune, LLC and has a medical device testing center in China.

  • Boston Analytical is the life sciences division of Alpha Analytical and provides a variety of quality analytical testing services to support CMC for developing drug & release testing, including microbiology testing, analytical development testing, and complete stability testing. The company has an ISO/IEC-17025:2005 certified laboratory, which is FDA & DEA registered, and cGMP compliant. The company serves medical device, biopharmaceutical, and pharmaceutical companies globally. It also serves other industries such as packaging, plastic & polymers, nutraceutical & supplement, home health & beauty, and consumer products.

  • Charles River Laboratories International, Inc. is a provider of clinical laboratory services and preclinical services for pharmaceutical and biotechnology industries. It operates through three segments: Discovery & Safety Assessment (DSA), Research Models & Services (RMS), and Manufacturing Support. Its DSA segment offerings include bioanalysis, drug metabolism, toxicology, and pharmacokinetics services. It offers its products & services to biotechnology & pharmaceutical companies, medical device companies, hospitals, clinics, and academic institutions.

  • West Pharmaceutical Services Inc. manufactures delivery systems and containments for injectable medicines. The company caters to the needs of biotechnology, medical devices, pharmaceutical, and generic companies. The company also offers contract manufacturing services. The company manufactures stoppers & seals for blood collection, drug packaging, injection systems, drug packaging, and syringe components. It operates in the Americas, Asia Pacific, & Europe, and has affiliates in Mexico & Japan.

Value chain-based sizing & forecasting

Supply Side Estimates

  • Company revenue estimation via referring to annual reports, investor presentations, and Hoover’s.

  • Segment revenue determination via variable analysis and penetration modeling.

  • Competitive benchmarking to identify market leaders and their collective revenue shares.

  • Forecasting via analyzing commercialization rates, pipelines, market initiatives, distribution networks, etc.

Demand side estimates

  • Identifying parent markets and ancillary markets

  • Segment penetration analysis to obtain pertinent

  • revenue/volume

  • Heuristic forecasting with the help of subject matter experts

  • Forecasting via variable analysis

Pharmaceutical Analytical Testing Outsourcing Market Report Objectives:

  • Understanding market dynamics (in terms of drivers, restraints, & opportunities) in the countries.

  • Understanding trends & variables in the individual countries & their impact on growth and using analytical tools to provide high-level insights into the market dynamics and the associated growth pattern.

  • Understanding market estimates and forecasts (with the base year as 2022, historic information from 2018 to 2021, and forecast from 2023 to 2030). Regional estimates & forecasts for each category are available and are summed up to form the global market estimates.

Pharmaceutical Analytical Testing Outsourcing Market Report Assumptions:

  • The report provides market value for the base year 2022 and a yearly forecast till 2030 in terms of revenue/volume or both. The market for each of the segment outlooks has been provided on region & country basis for the above-mentioned forecast period.

  • The key industry dynamics, major technological trends, and application markets are evaluated to understand their impact on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis.

  • We have used the bottom-up approach for market sizing, analyzing key regional markets, dynamics, & trends for various products and end-users. The total market has been estimated by integrating the country markets.

  • All market estimates and forecasts have been validated through primary interviews with the key industry participants.

  • Inflation has not been accounted for to estimate and forecast the market.

  • Numbers may not add up due to rounding off.

  • Europe consists of EU-8, Central & Eastern Europe, along with the Commonwealth of Independent States (CIS).

  • Asia Pacific includes South Asia, East Asia, Southeast Asia, and Oceania (Australia & New Zealand).

  • Latin America includes Central American countries and the South American continent

  • Middle East includes Western Asia (as assigned by the UN Statistics Division) and the African continent.

Primary Research

GVR strives to procure the latest and unique information for reports directly from industry experts, which gives it a competitive edge. Quality is of utmost importance to us, therefore every year we focus on increasing our experts’ panel. Primary interviews are one of the critical steps in identifying recent market trends and scenarios. This process enables us to justify and validate our market estimates and forecasts to our clients. With more than 8,000 reports in our database, we have connected with some key opinion leaders across various domains, including healthcare, technology, consumer goods, and the chemical sector. Our process starts with identifying the right platform for a particular type of report, i.e., emails, LinkedIn, seminars, or telephonic conversation, as every report is unique and requires a differentiated approach.

We send out questionnaires to different experts from various regions/ countries, which is dependent on the following factors:

  • Report/Market scope: If the market study is global, we send questionnaires to industry experts across various regions, including North America, Europe, Asia Pacific, Latin America, and MEA.

  • Market Penetration: If the market is driven by technological advancements, population density, disease prevalence, or other factors, we identify experts and send out questionnaires based on region or country dominance.

The time to start receiving responses from industry experts varies based on how niche or well-penetrated the market is. Our reports include a detailed chapter on the KoL opinion section, which helps our clients understand the perspective of experts already in the market space.

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes data points, ranging from trend analyses to estimates and forecasts. See for yourself.

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now

Certified Icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.